Korea FDA Director Encourages More Joint Research Deals With MNCs - PharmAsia Summit
This article was originally published in PharmAsia News
Executive Summary
SAN FRANCISCO - Establishing more joint research collaborations among multinational pharma companies and Korean hospitals, research centers and local companies will be one of the key goals Korea FDA will pursue in coming years, Hong Soon-Wook, KFDA's Pharmaceutical Safety Policy Division Director told Elsevier Business Intelligence's PharmaAsia Summit, Oct. 25 in San Francisco